mail
versión imprimible
 
 

4th Annual Cell Engager Therapeutics Summit 2022 | May 24-26 2022 | Boston, MA

Evvnt Promotion / evvnt
-
24.05.2022 - 26.05.2022  Boston Park Plaza, 50 Park Plaza, 02116 Boston, USA
Time: 09:00 - 15:00
 
Temas de la conferencia
With TCEs being studied in both hematological and solid tumors (39 and 34 trials respectively), there are now more than one hundred projects in the preclinical stage.
Early clinical outcomes and novel TCE design modifications have fueled the development and clinical advancement of over 65 bispecific T-cell engagers (TCEs), which are presently in Phase I and Phase II investigations since the Cell Engager Series began.
Organizador profesional (PCO)
Hanson Wade
Observaciones
Speakers: Antara Banerjee Associate Director, Immunology Research and Group Leader, Immuno Biologics Takeda Pharmaceutical Co. Ltd., Julie Bailis Director of Research Amgen Inc and more.
 

Información e inscripción:

https://go.evvnt.com/1011482-1?pid=4832
Ms. Rosie Andre
 
Categorías
Medicina General
Idioma
Inglés
Cuota del Congreso
USD 2599.0 - USD 4648.0
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

OÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation AMREF - African Medical and Research FoundationnewTreeAnästhesie in Entwicklungsländern e. V.Ärztekammer für WienAGEM - Arbeitsgemeinschaft Ethnologie und MedizinAlumni Club Medizinische Universität WienCenter of Excellence